Your browser doesn't support javascript.
loading
Self-reported caffeine consumption miss-matched consumption measured by plasma levels of caffeine and its metabolites: results from two population-based studies.
Laaboub, Nermine; Ranjbar, Setareh; Strippoli, Marie-Pierre F; Marques-Vidal, Pedro; Estoppey-Younes, Sandrine; Ponte, Belen; Pruijm, Menno; Vogt, Bruno; Ansermot, Nicolas; Crettol, Séverine; Vandenberghe, Frederik; Vollenweider, Peter; Preisig, Martin; Bochud, Murielle; Eap, Chin B.
Afiliación
  • Laaboub N; Unit of Pharmacogenetics and Clinical Psychopharmacology, Department of Psychiatry, Centre for Psychiatric Neuroscience, Lausanne University Hospital, University of Lausanne, Prilly, Switzerland.
  • Ranjbar S; Psychiatric Epidemiology and Psychopathology Research Center, Department of Psychiatry, Lausanne University Hospital, University of Lausanne, Prilly, Switzerland.
  • Strippoli MF; Psychiatric Epidemiology and Psychopathology Research Center, Department of Psychiatry, Lausanne University Hospital, University of Lausanne, Prilly, Switzerland.
  • Marques-Vidal P; Department of Internal Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Estoppey-Younes S; Centre for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.
  • Ponte B; Division of Nephrology, Geneva University Hospitals, Geneva, Switzerland.
  • Pruijm M; Service of Nephrology and Hypertension, University Hospital of Lausanne and University of Lausanne, Lausanne, Switzerland.
  • Vogt B; Department of Nephrology and Hypertension, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Ansermot N; Unit of Pharmacogenetics and Clinical Psychopharmacology, Department of Psychiatry, Centre for Psychiatric Neuroscience, Lausanne University Hospital, University of Lausanne, Prilly, Switzerland.
  • Crettol S; Unit of Pharmacogenetics and Clinical Psychopharmacology, Department of Psychiatry, Centre for Psychiatric Neuroscience, Lausanne University Hospital, University of Lausanne, Prilly, Switzerland.
  • Vandenberghe F; Unit of Pharmacogenetics and Clinical Psychopharmacology, Department of Psychiatry, Centre for Psychiatric Neuroscience, Lausanne University Hospital, University of Lausanne, Prilly, Switzerland.
  • Vollenweider P; Department of Internal Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Preisig M; Psychiatric Epidemiology and Psychopathology Research Center, Department of Psychiatry, Lausanne University Hospital, University of Lausanne, Prilly, Switzerland.
  • Bochud M; Centre for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.
  • Eap CB; Unit of Pharmacogenetics and Clinical Psychopharmacology, Department of Psychiatry, Centre for Psychiatric Neuroscience, Lausanne University Hospital, University of Lausanne, Prilly, Switzerland. chin.eap@chuv.ch.
Eur J Nutr ; 2024 May 04.
Article en En | MEDLINE | ID: mdl-38703227
ABSTRACT
IMPORTANCE AND

OBJECTIVE:

Self-reported caffeine consumption has been widely used in research while it may be subject to bias. We sought to investigate the associations between self-reported caffeine consumption and plasma levels of caffeine and its two main metabolites (paraxanthine and theophylline) in the community.

METHODS:

Data from two population-based studies (SKIPOGH1 and 2 (N = 1246) and CoLaus|PsyCoLaus (N = 4461)) conducted in Switzerland were used. Self-reported caffeine consumption was assessed using questionnaires. Plasma levels of caffeine and its metabolites were quantified by ultra-high performance liquid chromatography coupled to a tandem quadrupole mass spectrometer.

RESULTS:

In both studies, mean log plasma levels of caffeine and its two metabolites were over 6.48 (plasma levels = 652 ng/ml) when no caffeine consumption was reported. Subsequently, nonlinear associations between log plasma levels and self-reported caffeine consumption were observed in SKIPOGH, with a change of the slope at 3-5 cups of espresso per day in SKIPOGH1 but not SKIPOGH2. In CoLaus|PsyCoLaus, increased daily consumption of caffeinated beverages was associated with increased log plasma levels with a change of the slope at 3 cups. In both studies, declared caffeine consumption higher than 3-5 cups per day was not associated with higher plasma levels of caffeine and its metabolites.

CONCLUSION:

Self-reports of no or low caffeine consumption and consumption of more than 3-5 cups of coffee should be interpreted with caution, with possible under- or over-estimation. Quantifying plasma levels of caffeine and its metabolites may contribute to a better estimation of caffeine intake.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Eur J Nutr Asunto de la revista: CIENCIAS DA NUTRICAO Año: 2024 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Eur J Nutr Asunto de la revista: CIENCIAS DA NUTRICAO Año: 2024 Tipo del documento: Article País de afiliación: Suiza
...